Intraocular collision tumour: case report and literature review

  • Sarah E. Coupland
  • Andrew Dodson
  • Hongxiang Liu
  • Ming-Qing Du
  • Martina Angi
  • Bertil E. Damato
Pathology

Abstract

Background

“Collision” tumours consist of different neoplasms coexisting within a single lesion. Whilst quite common in the skin, the gastrointestional tract, and the ovaries, intraocular collision tumours are exceedingly rare. We describe an exceptional case of a combined uveal melanoma and intraocular plasmacytoma.

Methods

Observational case report. A 61-year-old woman underwent enucleation for rubeotic glaucoma and cells in the anterior chamber after proton-beam radiotherapy of a cilio-choroidal melanoma of the right eye. Examination of the enucleated eye was performed with immunohistochemistry, multiplex ligation dependent probe amplification (MLPA), and polymerase chain reaction (PCR) for immunoglobulin heavy- and light-chain gene rearrangements. A review of the literature on ocular collision tumours and uveal involvement by plasma cell neoplasms was also performed.

Results

Morphological, immunophenotypical, and genotypical examination of the tumour revealed the co-existence of both a melanoma and a plasmacytoma within the choroid and ciliary body. The glaucoma was caused by extensive infiltration of the iris and trabecular meshwork by the plasmacytoma cells. Review of the literature revealed only four collision tumours involving the eyelid and three involving the choroid. All three intraocular collision tumours consisted of uveal melanoma and choroidal non-Hodgkin lymphoma. Uveal involvement by plasma cell neoplasms is also extremely rare, with only six reported cases.

Conclusions

This is the first documented intraocular collision tumour consisting of a uveal melanoma and isolated plasmacytoma. If a patient presents with ‘uveitis’ after proton-beam radiotherapy of a cilio-choroidal melanoma, there may be scope for performing biopsies to determine whether the lymphoid infiltrate is reactive or neoplastic.

Keywords

Collision tumour Choroidal melanoma Ciliary body extramedullary plasmacytoma 

Supplementary material

417_2012_2216_MOESM1_ESM.docx (37 kb)
ESM 1(DOCX 140 kb)

References

  1. 1.
    Weider N, Cote RJ, Suster S, Weiss LM (2003) Modern surgical pathology. Saunders, PhiladelphiaGoogle Scholar
  2. 2.
    Bige O, Demir A, Koyuncuoglu M, Secil M, Ulukus C, Saygili U (2009) Collision tumor: serous cystadenocarcinoma and dermoid cyst in the same ovary. Arch Gynecol Obstet 279:767–770PubMedCrossRefGoogle Scholar
  3. 3.
    Boyd AS, Rapini RP (1994) Cutaneous collision tumors. An analysis of 69 cases and review of the literature. Am J Dermatopathol 16:253–257PubMedCrossRefGoogle Scholar
  4. 4.
    Kleist B, Lasota J, Miettinen M (2010) Gastrointestinal stromal tumor and gastric adenocarcinoma collision tumors. Hum Pathol 41:1034–1039PubMedCrossRefGoogle Scholar
  5. 5.
    Kuchle M, Tiemann M, Holbach L, Naumann GO (1994) Necrotic malignant melanoma of the choroid and concurrent intraocular manifestation of malignant non-Hodgkin’s B cell lymphoma. Ophthalmologica 208:65–70PubMedCrossRefGoogle Scholar
  6. 6.
    Vlaskamp M, de Wolff-Rouendaal D, Jansen PM, Luyten GP (2012) Concomitant choroidal melanoma and non-hodgkin lymphoma in two adult patients: case report. Case Report Ophthalmol 3:209–213CrossRefGoogle Scholar
  7. 7.
    Damato B, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland SE (2009) Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 50:3048–3055PubMedCrossRefGoogle Scholar
  8. 8.
    van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257–2317PubMedCrossRefGoogle Scholar
  9. 9.
    Liu H, Bench AJ, Bacon CM, Payne K, Huang Y, Scott MA, Erber WN, Grant JW, Du MQ (2007) A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathology. Brit J Haematol 138:31–43CrossRefGoogle Scholar
  10. 10.
    Tunc M, Simmons ML, Char DH, Herndier B (1997) Non-Hodgkin lymphoma and Kaposi sarcoma in an eyelid of a patient with acquired immunodeficiency syndrome. Multiple viruses in pathogenesis. Arch Ophthalmol 115:1464–1466PubMedCrossRefGoogle Scholar
  11. 11.
    Levy J, Cagnano E, Benharroch D, Monos T, Lifshitz T (2006) Collision sebaceous and basal cell carcinomas of the eyelid. Ann Diagn Pathol 10:157–159PubMedCrossRefGoogle Scholar
  12. 12.
    Shams PN, Olver JM (2006) A case of cutaneous collision tumour: the importance of photographic documentation and large incisional biopsy. Eye (Lond) 20:1324–1325CrossRefGoogle Scholar
  13. 13.
    Proia AD, Selim MA, Reutter JC, Michon JJ (2006) Basal cell-signet-ring squamous cell carcinoma of the eyelid. Arch Pathol Lab Med 130:393–396PubMedGoogle Scholar
  14. 14.
    Damato B, Coupland SE (2008) Managing patients with ocular melanoma: state of the art. Clin Experiment Ophthalmol 36:589–590PubMedCrossRefGoogle Scholar
  15. 15.
    Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE (1997) Survey of 520 eyes with uveal metastases. Ophthalmology 104:1265–1276PubMedGoogle Scholar
  16. 16.
    Coupland SE, Damato B (2008) Understanding intraocular lymphomas. Clin Experiment Ophthalmol 36:564–578PubMedCrossRefGoogle Scholar
  17. 17.
    Sanders TE, Podos SM, Rosenbaum LJ (1967) Intraocular manifestations of multiple myeloma. Arch Ophthalmol 77:789–794PubMedCrossRefGoogle Scholar
  18. 18.
    Shields CL, Chong WH, Ehya H, Shields JA (2007) Sequential bilateral solitary extramedullary plasmacytoma of the ciliary body. Cornea 26:759–761PubMedCrossRefGoogle Scholar
  19. 19.
    Honavar SG, Shields JA, Shields CL, Demirci H, Ehya H (2001) Extramedullary plasmacytoma confined to the choroid. Am J Ophthalmol 131:277–278PubMedCrossRefGoogle Scholar
  20. 20.
    Morgan AE, Shields JA, Shields CL, Piccone MR, Harrison SA (2003) Presumed malignant plasmacytoma of the choroid as the first manifestation of multiple myeloma. Retina 23:867–868PubMedCrossRefGoogle Scholar
  21. 21.
    Sandberg HO, Westby RK, Arnesen K (1989) Plasmacytoma of the uvea in a case of multiple myeloma. Acta Ophthalmol 67:329–332Google Scholar
  22. 22.
    Shakin EP, Augsburger JJ, Eagle RC Jr, Ehya H, Shields JA, Fischer D, Koepsell DG (1988) Multiple myeloma involving the iris. Arch Ophthalmol 106:524–526PubMedCrossRefGoogle Scholar
  23. 23.
    Adkins JW, Shields JA, Shields CL, Eagle RC Jr, Flanagan JC, Campanella PC (1996) Plasmacytoma of the eye and orbit. Int Ophthalmol 20:339–343PubMedGoogle Scholar
  24. 24.
    Rothova A, Ooijman F, Kerkhoff F, Van Der Lelij A, Lokhorst HM (2001) Uveitis masquerade syndromes. Ophthalmology 108:386–399PubMedCrossRefGoogle Scholar
  25. 25.
    Aronson SB 2nd, Shaw R (1959) Corneal crystals in multiple myeloma. AMA Arch Ophthalmol 61:541–546PubMedCrossRefGoogle Scholar
  26. 26.
    Klintworth GK, Bredehoeft SJ, Reed JW (1978) Analysis of corneal crystalline deposits in multiple myeloma. Am J Ophthalmol 86:303–313PubMedGoogle Scholar
  27. 27.
    Hawkins AS, Stein RM, Gaines BI, Deutsch TA (2001) Ocular deposition of copper associated with multiple myeloma. Am J Ophthalmol 131:257–259PubMedCrossRefGoogle Scholar
  28. 28.
    Slansky HH, Bronstein M, Gartner S (1966) Ciliary body cysts in multiple myeloma. Their relation to urethane, hyperproteinemia, and duration of the disease. Arch Ophthalmol 76:686–689PubMedCrossRefGoogle Scholar
  29. 29.
    Allen RA, Miller DH, Straatsma BR (1961) Cysts of the posterior ciliary body (pars plana). Arch Ophthalmol 66:302–313PubMedCrossRefGoogle Scholar
  30. 30.
    Sanders TE, Podos S (1966) Pars plana cysts in multiple myeloma. Trans Am Acad Ophthalmol Otolaryngol 70: 951–958PubMedGoogle Scholar
  31. 31.
    Fung S, Selva D, Leibovitch I, Hsuan J, Crompton J (2005) Ophthalmic manifestations of multiple myeloma. Ophthalmologica 219:43–48PubMedCrossRefGoogle Scholar
  32. 32.
    Ashton N (1965) Ocular changes in multiple myelomatosis. Arch Ophthalmol 73:487–494PubMedCrossRefGoogle Scholar
  33. 33.
    Bataille R (1982) Localized plasmacytomas. Clin Haematol 11:113–122PubMedGoogle Scholar
  34. 34.
    Knapp AJ, Gartner S, Henkind P (1987) Multiple myeloma and its ocular manifestations. Surv Ophthalmol 31:343–351PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Sarah E. Coupland
    • 1
  • Andrew Dodson
    • 1
  • Hongxiang Liu
    • 2
  • Ming-Qing Du
    • 3
  • Martina Angi
    • 1
  • Bertil E. Damato
    • 4
  1. 1.Department of Molecular and Clinical Cancer MedicineUniversity of LiverpoolLiverpoolUK
  2. 2.Molecular Malignancy Laboratory and Department of HistopathologyAddenbrooke’s Hospital, Cambridge Hospitals NHS Foundation TrustCambridgeUK
  3. 3.Department of PathologyUniversity of CambridgeCambridgeUK
  4. 4.Liverpool Ocular Oncology CentreRoyal Liverpool University HospitalLiverpoolUK

Personalised recommendations